Literature DB >> 27168441

Antilymphocyte Globulin for Chronic Graft-versus-Host Disease.

Nicolaus Kröger, Carlos Solano, Francesca Bonifazi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27168441     DOI： 10.1056/NEJMc1601364

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Recipient BCL2 inhibition and NK cell ablation form part of a reduced intensity conditioning regime that improves allo-bone marrow transplantation outcomes.

Authors:  Yuhao Jiao; Joanne E Davis; Jai Rautela; Emma M Carrington; Mandy J Ludford-Menting; Wilford Goh; Rebecca B Delconte; Fernando Souza-Fonseca-Guimaraes; Rachel Koldej; Daniel Gray; David Huang; Ben T Kile; Andrew M Lew; David S Ritchie; Nicholas D Huntington
Journal:  Cell Death Differ       Date:  2018-11-12       Impact factor: 15.828

2.  Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Governs GVHD and Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors.

Authors:  Fabrizio Carnevale-Schianca; Daniela Caravelli; Susanna Gallo; Paolo Becco; Luca Paruzzo; Stefano Poletto; Alessandra Polo; Monica Mangioni; Milena Salierno; Massimo Berger; Rosanna Pessolano; Francesco Saglio; Daniela Gottardi; Delia Rota-Scalabrini; Giovanni Grignani; Marco Fizzotti; Ivana Ferrero; Pio Manlio Mirko Frascione; Lorenzo D'Ambrosio; Valentina Gaidano; Loretta Gammaitoni; Dario Sangiolo; Andrea Saglietto; Elena Vassallo; Alessandro Cignetti; Massimo Aglietta; Franca Fagioli
Journal:  J Clin Med       Date:  2021-03-11       Impact factor: 4.241

3.  Hematopoietic stem cell transplantation for thalassemia major using HLA fully-matched and mismatched donor grafts.

Authors:  Chuwen Huang; Yuhua Qu; Sha Liu; Shushan Nie; Hua Jiang
Journal:  Transl Pediatr       Date:  2021-06

4.  Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT.

Authors:  Annalisa Ruggeri; Myriam Labopin; Andrea Bacigalupo; Boris Afanasyev; Jan J Cornelissen; Ahmet Elmaagacli; Maija Itälä-Remes; Didier Blaise; Ellen Meijer; Yener Koc; Noel Milpied; Harry C Schouten; Nicolaus Kroeger; Mohamad Mohty; Arnon Nagler
Journal:  J Hematol Oncol       Date:  2018-03-15       Impact factor: 17.388

5.  Similar transplant outcomes between haploidentical and unrelated donors after reduced-intensity conditioning with busulfan, fludarabine, and anti-thymocyte globulin in patients with acute leukemia or myelodysplastic syndrome.

Authors:  Mihong Choi; Ja Yoon Heo; Dong-Yeop Shin; Ji Yun Lee; Youngil Koh; Junshik Hong; Inho Kim; Sung-Soo Yoon; Jeong-Ok Lee; Soo-Mee Bang
Journal:  Blood Res       Date:  2020-03-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.